STAT

AUGUST 22, 2024

  The gift, from Columbia alumni Roy and Diana Vagelos, is the largest single donation given to the school and brings to $900 million the total given to Columbia by the couple since 2010. Roy Vagelos is widely known in medicine as the former chair and CEO of the drugmaker Merck. Read the rest…

Medical Schools 143

Medical Schools 143

STAT

JUNE 6, 2024

The Patient Protection and Affordable Care Act , (generally known as the ACA), was signed into law in 2010. It expanded access to affordable, quality health care, and today is helping 45 million people — the highest total on record — be covered by health insurance.

Vaccines 145

Vaccines Insurance 145

Fierce Healthcare

JUNE 18, 2024

healthcare spending in two decades when it was established in 2010, but it has instead increased costs by more than $5 billion. Republicans on the House Energy and Commerce Committee lambasted the failure of CMS’ Innovation Center to save U.S. healthcare dollars during a recent hearing on value-based care. |

121

121

STAT

NOVEMBER 3, 2022

It was 2010. I was standing by the Long Island Sound in Sachem’s Head, Conn., in the shadow of an 11-foot-tall granite Stonehenge replica built by Jonathan Rothberg, a biotech entrepreneur, as he talked up his newest gadget, a tabletop DNA sequencer. Read the rest…

FDA 131

FDA 131

STAT

AUGUST 19, 2024

He lamented last week how antitrust reviewers at Lina Khan’s Federal Trade Commission and Jonathan Kanter’s Antitrust Division at the Department of Justice are increasingly thwarting or stalling deals that have proliferated since the law went into effect in 2010.    Continue to STAT+ to read the full story…

Insurance 145

Insurance Hospitals 145

STAT

JUNE 10, 2024

  In a paper published in JAMA Internal Medicine on Monday, researchers found that the percentage of women represented in high-risk medical device trials did not increase from 2010 to 2020. Women generally made up just 33% of participants when the team reviewed 195 trials published from 2016 to 2022.

FDA 138

FDA 138

STAT

JUNE 17, 2024

Perryman led the company from 2010 to 2019.  Under CEO Laura Perryman’s leadership, the company warped the design of their devices to earn more reimbursement money from insurers, resulting in unnecessary plastic parts that allowed doctors to claim around $18,000 more than they previously could. attorney Damian Williams.

Insurance 133

Insurance FDA 133

Fierce Healthcare

SEPTEMBER 6, 2023

When the Affordable Care Act (ACA) was passed in 2010, the legislation set forth requirements for insurers to cover lactation services for mothers, a stark contrast from expecting families to pay o | The Affordable Care Act says insurance companies must front the cost for lactation care.

Insurance 110

Insurance 110

Drug Store News

JUNE 7, 2023

Joe V’s Smart Shop by H-E-B is an innovative price format the company launched in 2010.

97

97

STAT

SEPTEMBER 6, 2023

Congress previously drew this dubious distinction in 2010, when the biosimilar pathway it set up via the Biologics Price Competition and Innovation Act (BPCIA) conferred 12 years of data exclusivity on originator biologics, seven more than is given to originator small molecules under the Hatch-Waxman Act.

132

132

Fierce Healthcare

AUGUST 30, 2023

As large employers take a step back from self-insurance, small- and medium-sized employers are taking a step forward in embracing that coverage option, according to an issue brief by the Employee B | The share of large employers offering self-insurance options to employees steadily declined since the passage of the Affordable Care Act, with it dropping (..)

Insurance 110

Insurance 110

STAT

MARCH 26, 2024

From 1919 to 1952, more than 20,000 nonconsensual sterilizations took place in that state; the law was not repealed until 1979 in state hospitals and, frighteningly, was still in effect in state prisons until 2010. Read the rest…

Insurance 126

Insurance Hospitals 126

STAT

DECEMBER 20, 2023

  Laura Perryman led Stimwave, which sold nerve stimulation devices to combat pain, from 2010 to 2019, when the fraud came to light. The Securities and Exchange Commission on Tuesday charged the former CEO of Stimwave, a company that sold devices containing dummy pieces of plastic, with defrauding investors out of $41 million. 

Insurance 133

Insurance 133

STAT

SEPTEMBER 29, 2024

A Steward spokesperson did not say on Saturday if de la Torre will remain a major shareholder in the company he helped found in Boston in 2010. Continue to STAT+ to read the full story…

Hospitals 113

Hospitals 113

STAT

MARCH 7, 2024

Laura Perryman led Stimwave, which sold nerve stimulation devices to combat pain, from 2010 to 2019. A New York jury on Wednesday convicted the former CEO of Stimwave, a company that sold devices with dummy pieces of plastic, on two counts of health care fraud. The maximum jail sentence for each count is 20 years.

Insurance 126

Insurance 126

STAT

MAY 8, 2023

That’s according to Gail Wilensky, who has been on the board of Geisinger since 2010. A long-running flurry of hospital and medical group acquisitions in Pennsylvania — especially among the giants UPMC and Highmark Health — forced Geisinger to make a bigger move of its own and to sell to Kaiser Permanente.

Hospitals 98

Hospitals Insurance 98

The Guardian - Pharmaceutical Industry

AUGUST 24, 2024

The chancellor, Rachel Reeves, warns that hard choices on tax, spending and borrowing need to be made on 30 October when she delivers the first Labour budget since 2010, so poor is the economic legacy. The chancellor must step in Just how bad is the economy? Phooey, respond those still standing in the shredded Tory party.

100

100

STAT

MARCH 26, 2024

Foundation, established in 2010 and later acquired by the Swiss drug giant Roche, had workers scattered among four locations, including its former headquarters in Cambridge.

108

108

STAT

JANUARY 10, 2023

The Food and Drug Administration approved 378 new drugs between 2010 and 2019, a big chunk of which were cancer medicines. The returns on biotech stocks were phenomenal.

101

101

STAT

JULY 6, 2023

business and was part of the team charged with evaluating Avid Radiopharmaceuticals, which Lilly would go on to purchase in 2010 for a paltry $300 million — couch change for a multibillion-dollar firm. At the time, David Ricks was running Lilly’s U.S.

101

101

pharmaphorum

MAY 6, 2021

McKenna has been with STEM since 2010, founding it in the US and Brazil before taking over the CEO role from co-founder Rob Wood in 2018. He will oversee the online performance marketing and digital benchmarking agency’s growth in the US joins Rob Wood and Barrie Brien on performance-io’s non-executive board.

119

119

STAT

FEBRUARY 14, 2024

WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

96

96

STAT

AUGUST 8, 2023

White House budget experts are reviewing changes to the regulation of broadcast drug advertisements that the Food and Drug Administration proposed in 2010 , according to the Office of Management and Budget website. That proposal aimed to make commercials present drug risks in a manner that consumers notice and understand.

FDA 98

FDA 98

STAT

AUGUST 23, 2023

When President Obama signed the ACA into law on March 23, 2010, reproductive health took a giant step forward with its commonsense yet revolutionary approach. Barbara Mikulski — fought for coverage of women’s preventive services like mammograms, cervical cancer screenings, prenatal care, and, yes, contraception.

Insurance 97

Insurance FDA 97

IDStewardship

JUNE 18, 2023

ID Podcasts’ first podcast, “A Tour of the London Museum of Science,” was posted in June 2007. From there, our content grew rapidly – we commemorated our 100 th podcast in November 2009, and our first early smartphone apps were released in May 2010. We celebrated our 15 th anniversary in 2022.

Hospitals 217

Hospitals 217

Pharmaceutical Technology

JUNE 12, 2023

Currently, Jazz Pharmaceuticals’s nabiximols is the only cannabinoid approved for pain, receiving approval in Israel, in August 2010. In 2022, Pfizer acquired the drug, with the promise of accelerating clinical development via new, differentiated, and best-in-class approaches, enhancing optimism for further drug development.

Immunization 143

Immunization FDA 143

pharmaphorum

SEPTEMBER 24, 2020

The charges relate to a period from 2007 until the end of 2010, when the Department of Justice alleges California-based Gilead routinely obtained data from the foundation detailing how much the foundation had spent for patients on Letairis.

Insurance 98

Insurance 98

European Pharmaceutical Review

AUGUST 26, 2022

Moderna has filed patent infringement lawsuits alleging that Pfizer and BioNTech’s COVID-19 vaccine Comirnaty ® infringes patents Moderna filed between 2010 and 2016 covering its foundational messenger RNA (mRNA) technology.

Vaccines 98

Vaccines Immunization 98

Fierce Healthcare

AUGUST 4, 2023

Between 2010 and 2022, U.S. | A recent analysis of 2010-2022 data found that the year before and after closing a merger are risky for hospitals, due to their higher public profile and the marriage of mismatching data systems.

Hospitals 52

Hospitals 52

IDStewardship

FEBRUARY 12, 2025

coli labeled as susceptible in 2010 may be labeled as resistant in 2025. MIC breakpoints can change over time CLSI and other similar bodies change breakpoints periodically based on epidemiological data and other emerging information. This means that the same E. CLSI releases updates on which breakpoints are changing and why.

Labelling 130

Labelling 130

IDStewardship

MARCH 12, 2023

BCPS, BCIDP Article Posted 12 March 2023 As a pharmacist serving as a preceptor to students and residents in the area of infectious diseases since 2010, I have always been on the hunt for good infectious diseases journal articles for my learners to read. Authored by: Timothy P. Gauthier, Pharm.D.,

Medication Guidelines 299

Medication Guidelines Documentation Labelling Hospitals 299

The FDA Law Blog

AUGUST 12, 2024

In February 2010, an oral formulation of BRAVECTO, a medication to treat and prevent fleas and tick infestation in dogs, was the subject of an INAD submitted to the Agency. With this decision, the testing phase for BRAVECTO began on February 19, 2010, giving Plaintiffs an additional year to be included in its testing phase calculations.

FDA 59

FDA 59

pharmaphorum

MARCH 19, 2021

She is founder and host of the podcast and television segment “Human Condition MD” She graduated from George Washington University School Of Medicine in 2010. She is routinely seen on CBS, FOX 5, NBC, ABC and MHz Networks. Based in London, Catherine has international experience and reported from across Europe, the U.S

Compounding 141

Compounding Pharmaceutical Companies Pharmaceutical Companies Communication 141

Pharmaceutical Commerce

JANUARY 25, 2024

Tesamorelin (Egrifta) was initially approved by the FDA in November 2010 for the treatment of lipodystrophy in patients also diagnosed with HIV.

FDA 52

FDA 52

European Pharmaceutical Review

MARCH 31, 2023

billion in total venture financing raised from 2010 to 2022 for drug development In 2018 alone, the company invested over $400 million in venture financing. GlobalData Pharma Intelligence Center Deals Database found: SVB Financial Group and its subsidiaries were involved in more than $1.4

98

98

pharmaphorum

APRIL 30, 2021

The settlement resolves allegations that from 2010 to 2015, Indivior promoted sale of Suboxone to doctors who were writing unnecessary and unsafe precriptions. Indivior will pay just under $204 million to Medicaid while the remainder will go to the states for their Medicaid recovery. California’s share of the settlement is just over $1.64

98

98

European Pharmaceutical Review

APRIL 2, 2024

Before joining Siegfried in 2010, Wienand worked at the German specialty chemicals company Evonik Industries, Lonza highlighted. Baehny has held his Chief Executive Officer ad interim role since October 2023 and will support Wienand through the transition period.

98

98